STAGNO, Fabio
 Distribuzione geografica
Continente #
NA - Nord America 1.290
AS - Asia 569
EU - Europa 479
SA - Sud America 165
AF - Africa 152
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.656
Nazione #
US - Stati Uniti d'America 1.257
SG - Singapore 239
IT - Italia 216
CN - Cina 189
BR - Brasile 150
CI - Costa d'Avorio 110
IE - Irlanda 90
DE - Germania 39
IN - India 36
SN - Senegal 28
CA - Canada 25
KR - Corea 23
UA - Ucraina 22
VN - Vietnam 21
GB - Regno Unito 20
RU - Federazione Russa 19
FI - Finlandia 14
SE - Svezia 11
ES - Italia 9
TR - Turchia 9
AR - Argentina 8
UZ - Uzbekistan 8
BD - Bangladesh 7
IQ - Iraq 7
PL - Polonia 7
CZ - Repubblica Ceca 6
JP - Giappone 6
FR - Francia 5
KE - Kenya 5
MX - Messico 5
NL - Olanda 5
AE - Emirati Arabi Uniti 4
HK - Hong Kong 4
ZA - Sudafrica 4
AT - Austria 3
BE - Belgio 3
LB - Libano 3
MA - Marocco 3
PY - Paraguay 3
EC - Ecuador 2
GR - Grecia 2
ID - Indonesia 2
JO - Giordania 2
KZ - Kazakistan 2
MY - Malesia 2
NG - Nigeria 2
NO - Norvegia 2
PE - Perù 2
SA - Arabia Saudita 2
CH - Svizzera 1
DO - Repubblica Dominicana 1
EU - Europa 1
GD - Grenada 1
HU - Ungheria 1
JM - Giamaica 1
LT - Lituania 1
LU - Lussemburgo 1
NP - Nepal 1
OM - Oman 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 2.656
Città #
Dallas 239
Santa Clara 202
Chandler 169
Singapore 141
Abidjan 110
Chicago 101
Dublin 90
Ashburn 58
Catania 51
Beijing 45
Hefei 44
Los Angeles 34
Civitanova Marche 33
Boardman 32
Dakar 27
Kochi 25
Houston 24
Cambridge 23
Lawrence 23
Seoul 23
Andover 22
New York 20
Jacksonville 18
São Paulo 17
Dong Ket 14
Munich 14
Des Moines 13
Grafing 13
The Dalles 13
Nanjing 12
Palermo 12
Wilmington 12
Columbus 9
Milan 8
Toronto 8
Montreal 7
Ottawa 7
Turku 7
Belo Horizonte 6
Brooklyn 6
Hanoi 6
Hanover 6
Saint Petersburg 6
Council Bluffs 5
Falls Church 5
Giardini-Naxos 5
Helsinki 5
Jiaxing 5
Rio de Janeiro 5
Rome 5
Tokyo 5
Bari 4
Boston 4
Brno 4
Buffalo 4
Hebei 4
Jinan 4
Johannesburg 4
Nairobi 4
Nanchang 4
Orem 4
Poplar 4
Santa Venerina 4
Warsaw 4
Belém 3
Bremen 3
Brussels 3
Curitiba 3
Dubai 3
Florence 3
Istanbul 3
Juiz de Fora 3
Osasco 3
Seattle 3
Stockholm 3
Tashkent 3
Tremestieri Etneo 3
Washington 3
Zhengzhou 3
Abuja 2
Aci Catena 2
Almaty 2
Amman 2
Assago 2
Asunción 2
Baghdad 2
Bauru 2
Bergamo 2
Bismarck 2
Boydton 2
Brasília 2
Buenos Aires 2
Campinas 2
Canoinhas 2
Casablanca 2
Comiso 2
Cotia 2
Elk Grove Village 2
Frankfurt am Main 2
Fremont 2
Totale 1.929
Nome #
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib 177
High BCR-ABL/GUSISlevels at diagnosis of chronic phase CML are associated with unfavorable responses to standard-dose imatinib 127
A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic 126
The Q-LAMP Method Represents a Valid and Rapid Alternative for the Detection of the BCR-ABL1 Rearrangement in Philadelphia-Positive Leukemias 122
In vitro apoptotic response of freshly isolated chronic myeloid leukemia cells to all-trans retinoic acid and cytosine arabinoside 119
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53 119
Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib 112
Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report 111
Colony-forming cell assay detecting the co-expression of JAK2 V617F and BCR-ABL1 in the same clone: A case report 110
A case of high-risk AML in a patient with advanced systemic mastocytosis 106
B-ALL relapses after autologous stem cell transplantation associated with a shift from e1a2 to e14a2 BCR-ABL transcripts: A case report 104
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients. 104
Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22) 102
Myeloma Patient With Brugada Syndrome and Successful Lenalidomide Treatment 99
SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation 97
Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report 93
Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP 92
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells 88
Uncommon long-term survival in a patient with chronic myeloid leukemia 84
Differences among young adults, adults and elderly chronic myeloid leukemia patients 83
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 83
Low serum levels of vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) in IFN-treated chronic myeloid leukemia (CML) patients 82
Evaluation of taxol cytotoxicity on B-CLL cells in vitro 80
Prospective assessment of NGS-detectable mutations in CML patients with non-optimal response: the NEXT-in-CML study 79
High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability 71
Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper 59
Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating Functions 54
No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript Level 49
Totale 2.732
Categoria #
all - tutte 9.823
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.823


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202184 0 0 0 0 29 7 8 1 17 1 5 16
2021/2022164 4 24 3 3 34 5 27 4 9 1 9 41
2022/2023432 28 48 16 50 31 64 1 80 85 5 18 6
2023/2024251 13 40 8 12 8 66 1 15 5 10 50 23
2024/2025902 12 147 37 83 171 115 77 36 34 52 90 48
2025/2026706 106 125 264 133 78 0 0 0 0 0 0 0
Totale 2.732